Mosliciguat, an inhaled treatment being developed by Pulmovant, was well tolerated and more effective than a placebo at improving blood flow through the lungs of adults with pulmonary hypertension associated with interstitial lung disease (PH-ILD), supporting its move into Phase 3 clinical testing, which is already underway. That’s…
Discussion
The PAH Initiative will once again host a live broadcast event — this time focusing on how oxygen therapy can become part of the care plan for people living with pulmonary arterial hypertension (PAH) — and registration for the free hour-long program is now open. The event, called…
Discussion
Pulmonary hypertension (PH) is a complicated disease, which makes it especially fascinating how many of its problems can apparently be solved by someone who learned about it 45 seconds ago. Those of us living with PH spend an extraordinary amount of time managing our own bodies. We…
Discussion
Through every up and down of my 19 years living with pulmonary hypertension (PH), one thing I could always rely on was my mom’s little black notebook. Without fail, she would pull it out of her bag at the beginning of every doctor appointment, pen in hand. The notebook…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
